The ability to self-reflect upon one’s beliefs and behavior, during the coronavirus disease 2019 (COVID-19) pandemic.
Insilico Medicine’s AI-driven approach yields promising PTPN2/N1 inhibitor for cancer immunotherapy
In recent years, cancer immunotherapy, exemplified by PD-1 and its ligand PD-L1 blockade, has made remarkable advances.